MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference
November 29 2019 - 9:00AM
MannKind Corporation (NASDAQ: MNKD), a company
focused on the development and commercialization of inhaled
therapeutic products for patients with diseases such as diabetes
and pulmonary arterial hypertension, announced today that it will
be featured as a presenting company at the Piper Jaffray 31st
Annual Healthcare Conference on Tuesday, December 3, 2019 at 3:30
p.m. (ET) at the Lotte New York Palace in New York City. Presenting
from the Company will be its Chief Executive Officer, Michael
Castagna. The presentation will be webcast
live. Interested parties can access a link to the live webcast
of the presentation from the News & Events section of the
Company's website at http://www.mannkindcorp.com. The webcast
replay will remain available for 14 days following the live
presentation.
About MannKind
CorporationMannKind Corporation (NASDAQ:MNKD) focuses
on the development and commercialization of inhaled therapeutic
products for patients with diseases such as diabetes and pulmonary
arterial hypertension. MannKind is currently
commercializing Afrezza® (insulin human) Inhalation Powder, the
Company's first FDA-approved product and the only orally
inhaled ultra rapid-acting mealtime insulin in the United
States, where it is available by prescription from pharmacies
nationwide. MannKind is headquartered in Westlake
Village, California, and has a state-of-the art manufacturing
facility in Danbury, Connecticut. The Company also employs
field sales and medical representatives across the U.S. For further
information, visit www.mannkindcorp.com.
Company
Contact:818-661-5000ir@mannkindcorp.com
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Mar 2024 to Apr 2024
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Apr 2023 to Apr 2024